Bone-Shark

CytoSorbents Corporation, listed on NASDAQ as CTSO, is a New Jersey-based critical care company that focuses on blood purification to address life-threatening conditions in the intensive care unit and during cardiac surgery. The company specializes in developing innovative solutions for critical care patients, offering advanced technologies to improve outcomes and save lives in high-risk medical situations. Generated from their website's infomation

NovoPedics, Inc. is a medical device company based in Monmouth Junction, NJ, specializing in the development of MeniscoFix, a resorbable implant designed to replace the medial or lateral meniscus of the knee. Their innovative product aims to alleviate pain, restore mobility, and prevent the onset of osteoarthritis in patients with severe meniscal injuries, offering advantages over existing alternatives. With Breakthrough Device Designation from the U.S. FDA and substantial funding from the U.S. Department of Defense, NovoPedics is at the forefront of addressing the unmet needs in knee surgery. Their team of experienced professionals, including medical experts and engineers, is dedicated to creating a load-sharing device that mimics the biomechanical properties of the native meniscus and gradually resorbs to support the development of functional new meniscus-like tissue.Generated from the website

CytoSorbents Corporation, listed on NASDAQ as CTSO, is a New Jersey-based critical care company that focuses on blood purification for treating life-threatening conditions in the intensive care unit and cardiac surgery. The company specializes in developing innovative technologies to improve patient outcomes and provide advanced solutions for critical care settings. Generated from their website's infomation